Physician profile
Michael A Basnight
NPI 1467453696
$3,333.04
in general payments reported to CMS, 2019-2025
23 companies · $15.00 in 2025
The $15.00 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $974 · 2020: $635 · 2021: $487 · 2022: $410 · 2023: $592 · 2024: $220 · 2025: $15.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $934.06 | 2019-2023 | Watchman Access System, Eluvia |
| Penumbra, INC. | $450.30 | 2019-2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $270.39 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $241.79 | 2021-2024 | |
| Abbott Laboratories | $234.99 | 2020-2023 | Jot Dx, Merlin@Home, Mitraclip |
| Amgen INC. | $201.88 | 2019-2024 | Repatha |
| Pfizer INC. | $194.37 | 2022-2024 | |
| Biotronik INC. | $167.36 | 2020 | |
| Medtronic Vascular, INC. | $136.48 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.04 | 2019-2022 | |
| Medtronic, INC. | $111.76 | 2023 | Azure Xt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.14 | 2019-2022 | |
| Astellas Pharma US INC | $28.69 | 2019-2020 | |
| Scpharmaceuticals INC. | $27.45 | 2024 | |
| Shockwave Medical, INC | $26.33 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24.96 | 2024 | Camzyos |
| Cardiva Medical, INC. | $23.62 | 2019 | |
| Abiomed | $23.13 | 2020 | |
| Terumo Medical Corporation | $20.84 | 2019 | |
| Philips North America LLC | $18.02 | 2022 | |
| Infobionic, INC | $12.76 | 2019 | |
| Preventice Services, LLC | $11.86 | 2020 | |
| Cvrx, INC. | $4.82 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Basnight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.